Table 2 Clinicopathologic feature of 71 mucinous breast cancers in 1760 breast carcinomas
From: Clinical significance of the sub-classification of 71 cases mucinous breast carcinoma
Parameters | MBC (n=71) | Non-MBC(n=1689) | p value |
|---|---|---|---|
Age at operation | 38 (53.5%) | 965 (57.1%) | 0.547 |
≤64 | 33 (46.5%) | 724 (42.9%) | |
>64 | |||
Pathological stage | 23 (32.4%) | 799 (47.3%) | 0.014 |
I | 48 (67.6%) | 890 (52.7%) | |
II and III | |||
pTumor size | 25 (35.2%) | 937 (55.5%) | 0.001 |
≤2 cm | 46 (64.8%) | 752 (45.5%) | |
>2 cm | |||
pLymph node status | 63 (88.7%) | 1270 (75.2%) | 0.009 |
Negative | 8 (11.3%) | 419 (24.8%) | |
Positive | |||
Lymphovascular invasion | 56 (78.9%) | 1276 (75.5%) | 0.522 |
Negative | 15 (21.1%) | 413 (24.5%) | |
Positive | |||
HR (ER and/or PR) | 3 (4.2%) | 477 (28.2%) | < 0.001 |
Negative | 68 (95.8%) | 1212 (71.8%) | |
Positive | |||
HER 2 status | 70 (98.6%) | 1310 (77.6%) | < 0.001 |
Negative | 1 (1.4%) | 379 (22.4%) | |
Positive |